Sunday - May 5, 2024
Public Policy Tipoffs Involving California Newsletter for Monday April 08, 2024 ( 3 items )  

American Association for Cancer Research: A Biologic Drug-Device Combination Immunotherapy Shows Promise for Patients With Metastatic Prostate Cancer
SAN DIEGO, California, April 8 -- The American Association for Cancer Research issued the following news release: SYNC-T, an investigational therapy that combines a device-induced vaccination at the tumor site with intratumoral infusion of a multitarget biologic drug led to numerous clinical responses in patients with metastatic castrate-resistant prostate cancer (mCRPC), according to results reported at the American Association for Cancer Research (AACR) Annual Meeting 2024, held April 5-10.   more

American Association for Cancer Research: Fewer Than Half of Accelerated Approval Drugs Showed Clinical Benefit in Confirmatory Trials After Five Years
SAN DIEGO, California, April 8 (TNSres) -- The American Association for Cancer Research issued the following news release: Of the 46 cancer drugs that the U.S. Food and Drug Administration (FDA) granted accelerated approval between 2013-2017, 63% were converted to regular approval even though only 43% demonstrated a clinical benefit in confirmatory trials after more than five years of follow-up, according to a study presented at the American Association for Cancer Research (AACR) Annual Meeting  more

Rand Issues Commentary to Foreign Policy: U.S.-India Ties Remain Fundamentally Fragile
SANTA MONICA, California, April 8 (TNSres) -- Rand issued the following commentary to Foreign Policy on April 7, 2024: * * * U.S.-India Ties Remain Fundamentally Fragile * * * This commentary originally appeared on Foreign Policy on April 4, 2024. * * * By Derek Grossman For the United States, foreign policy has always been a mix of securing interests and promoting values, and India checks the box on multiple counts. Washington and New Delhi routinely highlight that the world's oldest dem  more